TNF and inflammatory bowel disease: The most severe IBD cases are commonly treated with immunosuppressive drugs (systemic steroids, methotrexate, thiopurines, calcineurin inhibitors, vedolizumab, anti-TNF agents, IL-12/IL-23 antibodies, and JAK inhibitors) that, although with significant differences, further reduce immune defense efficiency and favor infections (5).